Paradromics’ brain-computer interface (BCI) records brain activity at the highest possible resolution: the individual neuron. We translate each unique signal in real time, enabling the …

Learn more about the Paradromics team and our vision for the future of BCI technology

Paradromics will partner with leading healthcare companies to develop novel therapies for brain-related disorders. The investment demonstrates confidence in Paradromics as a well …

May 18, 2023 · AUSTIN, Texas /PRNewswire/ - Paradromics Inc., the leading developer of high data-rate brain-computer interfaces (BCI), today announced a $33 million Series A funding …

Read top stories about Paradromics and BCI featured in leading publications like Forbes, Washington Post, The Wall Street Journal and more.

Paradromics combined advanced neuroscience with medical device expertise to create Connexus, leaping beyond 30 years of brain-computer interface (BCI) research. Connexus is …

Paradromics is focused on using neurotechnology to help people regain daily function and connection with the world. For us, the most exciting future to live in is one where sensory …

What do neuroscience experts and industry leaders talk about over beers? Find out as they join Paradromics founder and CEO Matt Angle in long-form conversation. Each episode is a …

Jul 1, 2024 · The Paradromics Connexus® Direct Data Interface has received two such designations from the FDA: one recognizing its potential to help patients communicate again …

Paradromics awarded $3.2M from the National Institutes of Health (NIH) for the development and evaluation of novel, high-density intracortical microelectrode arrays for clinical applications